COVID-19 Roundup: Neural Nets Track Readmissions; ML Predicts Spread; Analyzing Brands’ Foot Traffic – & More
As the COVID-19 pandemic sweeps the globe, big data and AI have emerged as crucial tools for everything from diagnosis and epidemiology to therapeutic and vaccine development. Here, we collect the latest news in how big data is fighting back against COVID-19.
Analytics provider Information Builders has announced enhancements to its Omni-HealthData solution and new data visualizations and dashboards as part of its expanding COVID-19 Resource Center. The Omni-HealthData dashboard now tracks hospital readmissions and discharges by location, period, conditions, and more, and the Resource Center now includes a predictive model combining data from two neural networks. To read more, click here.
A team at the UCLA Samueli School of Engineering has developed a machine learning model to help the Centers for Disease Control and Prevention (CDC) predict the spread of COVID-19. The model is epidemiology-driven – rather than relying on confirmed cases and fatalities – and is one of only two models in the 13-model hub that uses machine learning. To read more about the model, click here.
The Inter-American Development Bank (IDB) and Esri have partnered to provide free access to geospatial technology that will help governments in Latin America and the Caribbean track critical equipment and assets, manage supply chains, and maintain continuity during the COVID-19 pandemic. To read more, click here.
Location data analytics firm Gravy Analytics has created dashboards illustrating how foot traffic is changing for 200 top brands across the U.S. The data can be broken down by state or by major city and businesses can be viewed either by brand or by sector. Gravy plans to produce additional dashboards using its location data. To view Gravy’s COVID-19 tools, click here, and to read more, click here.
A team of researchers from MIT have developed a new optimization framework that aims to minimize the loss of life during outbreaks by accelerating drug approvals when doing so would save lives on the balance. The same researchers also released a study that estimated the probabilities of success of clinical trials for vaccines and other therapeutics. To read more, click here.
AI software provider C3.ai has announced the addition of 11 new datasets to its COVID-19 Data Lake, which the company claims makes it “one of the largest pre-integrated and free sources of COVID-19 data in the world.” Furthermore, C3.ai is encouraging researchers to reach out to the company to commend datasets for inclusion in future versions of the Data Lake. To read more, click here.
CRM and marketing software developer Womply has unveiled a new dashboard, the Opportunity Insights Economic Tracker, that aims to track the economic impacts of the pandemic across the U.S. The dashboard uses billions of data points to generate a range of metrics, such as declines in consumer spending, job postings, hours worked at small businesses, and more. To read more, click here.